Lipid mediators influence immune responses by modulating the activity of various immune cells. For example, prostaglandins can suppress the function of T cells and macrophages, whereas leukotrienes can enhance the chemotaxis of neutrophils. Additionally, SPMs are known to facilitate the clearance of apoptotic cells and debris by macrophages, thus aiding in the resolution of inflammation and prevention of chronic inflammatory diseases.